Found: 79
Select item for more details and to access through your institution.
Rezidivmuster bei Patienten mit diffusem großzelligem B‑Zell-Lymphom nach „Involved-site“-Radiotherapie.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 7, p. 2117, doi. 10.1007/s00432-020-03495-1
- By:
- Publication type:
- Article
Struggling with extensive informed consent procedures for cancer trials-is there even a benefit for the patients?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Intravenous luteinizing hormone-releasing hormone has no effect on serum N-terminal pro-brain natriuretic peptide in children and adolescents.
- Published in:
- Pediatrics International, 2009, v. 51, n. 2, p. 283, doi. 10.1111/j.1442-200X.2008.02710.x
- By:
- Publication type:
- Article
Rituximab in the treatment of non-Hodgkin's lymphoma.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 4, p. 619
- By:
- Publication type:
- Article
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
- Published in:
- Kidney International, 2011, v. 79, n. 10, p. 1113, doi. 10.1038/ki.2010.554
- By:
- Publication type:
- Article
Effect of GB Virus C Coinfection on Response to Antiretroviral Treatment in Human Immunodeficiency Virus-Infected Patients.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 3, p. 504, doi. 10.1086/368206
- By:
- Publication type:
- Article
Detection of the Hepatitis G Virus Genome among Injecting Drug Users, Homosexual and Bisexual Men, and Blood Donors.
- Published in:
- Journal of Infectious Diseases, 1996, v. 174, n. 6, p. 1320, doi. 10.1093/infdis/174.6.1320
- By:
- Publication type:
- Article
Real‐world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR‐2 retrospective chart review study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 749, doi. 10.1111/bjh.18519
- By:
- Publication type:
- Article
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 482, doi. 10.1111/bjh.18161
- By:
- Publication type:
- Article
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 4, p. 586, doi. 10.1111/bjh.14920
- By:
- Publication type:
- Article
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 430, doi. 10.1111/bjh.14870
- By:
- Publication type:
- Article
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 40, doi. 10.1111/bjh.13380
- By:
- Publication type:
- Article
Rituximab combined with Dexa BEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 6, p. 824, doi. 10.1111/bjh.13234
- By:
- Publication type:
- Article
Vom Granatapfelbaum zum Cyclooctatetraen.
- Published in:
- Chemie in unserer Zeit, 2016, v. 50, n. 1, p. 34, doi. 10.1002/ciuz.201500729
- By:
- Publication type:
- Article
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
- By:
- Publication type:
- Article
Checkpoint-Inhibition bei Non-Hodgkin-Lymphom.
- Published in:
- Kompass Onkologie, 2018, v. 5, n. 1, p. 12, doi. 10.1159/000485673
- By:
- Publication type:
- Article
Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0006-1
- By:
- Publication type:
- Article
GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV)/HIV--Coinfected Patients Receiving HCV Treatment: Importance of the GBV-C Genotype.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 4, p. 410
- By:
- Publication type:
- Article
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1773, doi. 10.1007/s00277-023-05196-4
- By:
- Publication type:
- Article
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80-results from a single-center survey.
- Published in:
- 2021
- By:
- Publication type:
- journal article
High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction?: A cross-sectional study.
- Published in:
- BMC Cardiovascular Disorders, 2011, v. 11, n. 1, p. 41, doi. 10.1186/1471-2261-11-41
- By:
- Publication type:
- Article
Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 6, p. 849, doi. 10.1007/s00262-007-0421-1
- By:
- Publication type:
- Article
Checkpoint Inhibition in Non-Hodgkin's Lymphoma.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 11, p. 662, doi. 10.1159/000481888
- By:
- Publication type:
- Article
Chronic myelogenous leukemia molecular signature.
- Published in:
- Oncogene, 2003, v. 22, n. 25, p. 3952, doi. 10.1038/sj.onc.1206620
- By:
- Publication type:
- Article
Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
- Published in:
- Transfusion, 1988, v. 28, n. 4, p. 386, doi. 10.1046/j.1537-2995.1988.28488265274.x
- By:
- Publication type:
- Article
Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece.
- Published in:
- Journal of Medical Virology, 2000, v. 61, n. 3, p. 319, doi. 10.1002/1096-9071(200007)61:3<319::AID-JMV6>3.0.CO;2-R
- By:
- Publication type:
- Article
Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen.
- Published in:
- Journal of Medical Virology, 2000, v. 60, n. 2, p. 113, doi. 10.1002/(SICI)1096-9071(200002)60:2<113::AID-JMV2>3.0.CO;2-0
- By:
- Publication type:
- Article
Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.
- Published in:
- Journal of Medical Virology, 1999, v. 59, n. 1, p. 45, doi. 10.1002/(SICI)1096-9071(199909)59:1<45::AID-JMV8>3.0.CO;2-8
- By:
- Publication type:
- Article
Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
- Published in:
- Journal of Medical Virology, 1999, v. 57, n. 4, p. 370, doi. 10.1002/(SICI)1096-9071(199904)57:4<370::AID-JMV8>3.0.CO;2-K
- By:
- Publication type:
- Article
Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients.
- Published in:
- Journal of Medical Virology, 1996, v. 50, n. 1, p. 71, doi. 10.1002/(SICI)1096-9071(199609)50:1<71::AID-JMV12>3.0.CO;2-0
- By:
- Publication type:
- Article
Immunogenicity and safety of an inactivated hepatitis a vaccine in anti-HIV positive and negative homosexual men.
- Published in:
- Journal of Medical Virology, 1995, v. 46, n. 1, p. 40, doi. 10.1002/jmv.1890460109
- By:
- Publication type:
- Article
Immune blot analysis of viral surface proteins in serum and liver of patients with chronic hepatitis B virus infection.
- Published in:
- Journal of Medical Virology, 1989, v. 29, n. 4, p. 261, doi. 10.1002/jmv.1890290408
- By:
- Publication type:
- Article
Active immunization of homosexual men using a recombinant hepatitis B vaccine.
- Published in:
- Journal of Medical Virology, 1989, v. 29, n. 4, p. 229, doi. 10.1002/jmv.1890290402
- By:
- Publication type:
- Article
Reactivation of chronic type B hepatitis: The effect on expression of serum HBV-DNA and Pre-S encoded proteins.
- Published in:
- Journal of Medical Virology, 1988, v. 25, n. 2, p. 197, doi. 10.1002/jmv.1890250210
- By:
- Publication type:
- Article
Demonstration and partial characterization of an intermediate HBcAg (dane particle) population.
- Published in:
- Journal of Medical Virology, 1981, v. 7, n. 3, p. 241, doi. 10.1002/jmv.1890070309
- By:
- Publication type:
- Article
Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: Studies on its mode of action.
- Published in:
- Journal of Medical Virology, 1980, v. 5, n. 4, p. 309, doi. 10.1002/1096-9071(1980)5:4<309::AID-JMV1890050407>3.0.CO;2-L
- By:
- Publication type:
- Article
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 1, p. 61, doi. 10.1002/cam4.4422
- By:
- Publication type:
- Article
Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E33, doi. 10.3816/CLML.2010.n.043
- By:
- Publication type:
- Article
Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-022-06982-7
- By:
- Publication type:
- Article
Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-022-06982-7
- By:
- Publication type:
- Article
NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2009, v. 88, n. 2, p. 234, doi. 10.1080/00016340802596025
- By:
- Publication type:
- Article
Induction of γ-Interferon by Avarol in Human Peripheral Blood Lymphocytes.
- Published in:
- Cancer Science, 1988, v. 79, n. 5, p. 647, doi. 10.1111/j.1349-7006.1988.tb00035.x
- By:
- Publication type:
- Article
High-Sensitivity Cardiac Troponin T for Early Prediction of Evolving Non-ST-Segment Elevation Myocardial Infarction in Patients with Suspected Acute Coronary Syndrome and Negative Troponin Results on Admission.
- Published in:
- Clinical Chemistry, 2010, v. 56, n. 4, p. 642, doi. 10.1373/clinchem.2009.134460
- By:
- Publication type:
- Article
Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. 270, doi. 10.1016/j.clml.2021.10.005
- By:
- Publication type:
- Article
ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S392, doi. 10.1016/S2152-2650(21)01891-7
- By:
- Publication type:
- Article
Poster: ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01499-3
- By:
- Publication type:
- Article